Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease

Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …

Promising drug targets and associated therapeutic interventions in Parkinson's disease

SN Rai, P Singh, R Varshney… - Neural regeneration …, 2021 - journals.lww.com
Parkinson's disease (PD) is one of the most debilitating brain diseases. Despite the
availability of symptomatic treatments, response towards the health of PD patients remains …

[HTML][HTML] Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

K Zhang, S Zhu, J Li, T Jiang, L Feng, J Pei… - … Pharmaceutica Sinica B, 2021 - Elsevier
Abstract Parkinson's disease (PD), known as one of the most universal neurodegenerative
diseases, is a serious threat to the health of the elderly. The current treatment has been …

[HTML][HTML] Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease

L La Barbera, F Vedele, A Nobili, P Krashia… - Progress in …, 2021 - Elsevier
What happens precociously to the brain destined to develop Alzheimer's Disease (AD) still
remains to be elucidated and this is one reason why effective AD treatments are missing …

Emerging therapeutic strategies for Parkinson's disease and future prospects: A 2021 update

NA Gouda, A Elkamhawy, J Cho - Biomedicines, 2022 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disorder pathologically distinguished by
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle …

α-Synuclein in Parkinson's disease: causal or bystander?

P Riederer, D Berg, N Casadei, F Cheng… - Journal of neural …, 2019 - Springer
Parkinson's disease (PD) comprises a spectrum of disorders with differing subtypes, the vast
majority of which share Lewy bodies (LB) as a characteristic pathological hallmark. The …

The role of c-Abl tyrosine Kinase in brain and its pathologies

H Motaln, B Rogelj - Cells, 2023 - mdpi.com
Differentiated status, low regenerative capacity and complex signaling make neuronal
tissues highly susceptible to translating an imbalance in cell homeostasis into cell death …

Parkinson's disease modification through Abl kinase inhibition: an opportunity

MH Werner, CW Olanow - Movement Disorders, 2022 - Wiley Online Library
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease of the
central nervous system, with an estimated 5 000 000 cases worldwide. Historically …

Repositioning of drugs for Parkinson's disease and pharmaceutical nanotechnology tools for their optimization

H Hernández-Parra, H Cortés… - Journal of …, 2022 - Springer
Parkinson's disease (PD) significantly affects patients' quality of life and represents a high
economic burden for health systems. Given the lack of safe and effective treatments for PD …

Fyn tyrosine kinase elicits amyloid precursor protein Tyr682 phosphorylation in neurons from Alzheimer's disease patients

F Iannuzzi, R Sirabella, N Canu, TJ Maier… - Cells, 2020 - mdpi.com
Alzheimer's disease (AD) is an incurable neurodegenerative disorder with a few early
detection strategies. We previously proposed the amyloid precursor protein (APP) tyrosine …